Type and hit ENTER

News

All the posts published.

ProAxsis was delighted to support the recent School of Pharmacy Undergraduate Awards at Queen’s University, Belfast.  For the second year running, the …

October 25, 2019

ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman of the company’s Board of Directors with immediate …

October 25, 2019

Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the British Lung Foundation (BLF) …

June 3, 2019

The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed at the Winter meeting of the British Thoracic …

November 26, 2018

ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement of active protease biomarkers of disease, today announces …

September 20, 2018

ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement of active protease biomarkers of disease, today announces …

August 2, 2018

ProAxsis Limited has been declared as the “Innovative Business of the Year” at the Business Eye First Trust Awards (BEFTAs) for …

June 4, 2018

ProAxsis Limited has received an Invest NI Grant for Research and Development, supporting the company to develop new products using its innovative …

June 1, 2018

ProAxsis is proud to be collaborating with Dr. Gunnar Schroeder and Prof. Cliff Taggart from the School of Medicine, Dentistry and …

March 6, 2018

Having reached the first anniversary following relocation to its new purpose-built laboratory on the Catalyst Inc. site in the Titanic Quarter of …

November 21, 2017
News Archives | ProAxsis